Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

AMGN

287.61 USD
0.57
0.20%
Last update Jun 2, 3:28 PM EDT
Main market
Day range
284.775
289.45
Previous close
288.17999
Open
285.825
Access this stock data via API
Subscribe
Amgen Inc.
287.61
0.57
0.20%

Overview

Description

Amgen Inc. is a leading biotechnology company focused on the discovery, development, manufacturing, and marketing of human therapeutics. Established in 1980 and headquartered in Thousand Oaks, California, Amgen is recognized for pioneering biologic treatments and having a robust pipeline that targets critical areas like oncology, cardiovascular, and nephrology. The company has harnessed advanced technology platforms and deep scientific expertise to deliver innovative medicines such as Neulasta, Enbrel, and Prolia, which are significant players in the health care sector. Amgen serves markets globally, impacting the biotech industry by transforming the ways diseases are treated. Its investment in state-of-the-art manufacturing facilities and research makes it a significant entity in the pharmaceutical landscape, contributing to long-term health care solutions.

About

CEO
Mr. Robert A. Bradway
Employees
28000
Address
One Amgen Center Drive
Thousand Oaks, 91320-1799, CA
United States
Phone
805 447 1000
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
MIC code
XNGS
Main market

Exchange is currently active.
Closing in 29 minutes

15:30
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).